Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24503131.
- Also identified by DOI 10.1053/j.gastro.2014.01.059 and PMC identifier 3995857.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antibiotic-associated infection with the bacterial pathogen Clostridium difficile is a major cause of morbidity and increased health care costs. C difficile infection follows disruption of the indigenous gut microbiota by antibiotics. Antibiotics create an environment within the intestine that promotes C difficile spore germination, vegetative growth, and toxin production, leading to epithelial damage and colitis. Studies of patients with C difficile infection and animal models have shown that the indigenous microbiota can inhibit expansion and persistence of C difficile. Although the specific mechanisms of these processes are not known, they are likely to interfere with key aspects of the pathogen's physiology, including spore germination and competitive growth. Increasing our understanding of how the intestinal microbiota manage C difficile could lead to better means of controlling this important nosocomial pathogen.
Medical subject headings
- Clostridioides difficile
- Enterocolitis, Pseudomembranous
- Intestines
- Microbiota